CNMD, US2074101013

Argus raises target for CONMED stock to USD 48.00

Published on 10/25/2026 at 02:36 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Argus set a USD 48.00 target for CONMED stock on October 14, 2026. Third-quarter results are due October 28, 2026 at 4:30 p.m. ET.

Reporting calendar and valuation

Argus set a USD 48.00 target for CONMED on October 14, 2026.
CONMED reported USD 343.49 million in second-quarter revenue on July 29, 2026.
Third-quarter results are scheduled for October 28, 2026 after the market close.
CONMED had a USD 1.4 billion market capitalization on October 22, 2026.

CNMD, US2074101013, Illustration mit AI erstellt.

CONMED (ISIN US2074101013) drew an Argus target of USD 48.00 on October 14, 2026, according to Yahoo Finance. The analyst target arrives before the medical-device company's next quarterly report.

Target meets a cautious consensus

Argus's USD 48.00 target sits above the USD 41.40 average target reported for eight analysts by MarketBeat on October 22, 2026. That spread gives the Argus view a distinct position against the broader rating picture, which included six holds and two sells.

Three milestones shaped the setup

On July 29, 2026, CONMED reported second-quarter revenue of USD 343.49 million versus USD 337.60 million expected and adjusted earnings per share of USD 1.38 versus USD 1.11 consensus, according to MarketBeat.

On October 1, 2026, CONMED announced that it would publish third-quarter results on October 28, 2026 after the market close, according to Business Wire.

On October 14, 2026, Argus set its CONMED target at USD 48.00, a figure that now provides the clearest named analyst reference ahead of the report.

What will the October 28 report test?

The scheduled third-quarter release will test whether CONMED can extend the second quarter's USD 343.49 million revenue base while meeting the full-year adjusted earnings-per-share guidance of USD 4.48 to USD 4.60. The prior quarter's USD 1.38 adjusted earnings per share exceeded consensus by USD 0.27, creating a concrete benchmark for the next update.

Next date for investors

Business Wire states that CONMED will report third-quarter 2026 results after the market close on October 28, 2026, followed by a management conference call at 4:30 p.m. ET.

Valuation before the next report

CONMED had a USD 1.4 billion market capitalization on October 22, 2026. Its 52-week range was USD 31.44 to USD 53.66 on that date, placing the upcoming earnings release between a recent operating benchmark and a valuation range that still leaves room for a material response to the results.

The further course of trading is shown by the continuously updated real-time quote of CONMED stock.